DSP Global Innovation Overseas Equity Omni FoF - Regular - IDCW
Category: Fund of Funds-Overseas
Launch Date: 14-02-2022
AUM:
₹ 1,132.33 Cr
Expense Ratio
2.03%
Benchmark
MSCI All Country World TRI
ISIN
INF740KA1QN6
Minimum Investment
100.0
Minimum Topup
100.0
Minimum SIP Amount
100
Fund Manager
Kaivalya Nadkarni
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| DSP Global Innovation Overseas Equity Omni FoF - Regular - IDCW | 43.69 | 28.64 | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
22.2799
Last change
-0.05 (-0.2231%)
Fund Size (AUM)
₹ 1,132.33 Cr
Performance
20.33% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The primary investment objective of the scheme is to seek capital appreciation by investing in global mutual funds schemes and ETFs that primarily invest in companies with innovation theme having potential for higher revenue and earnings growth. The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP Mutual Fund, in order to meet liquidity requirements from time to time. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Manager
Kaivalya Nadkarni
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Bluebox Global Technology Fund | 38.75 |
| iShares NASDAQ 100 UCITS ETF | 28.54 |
| IVZ NASDAQ 100 EW ACC | 12.26 |
| KRANESHARES CSI CHINA INTRNT | 11.16 |
| TREPS / Reverse Repo Investments | 3.81 |
| Fidelity Select Medical Technology And Devices Portfolio | 3.37 |
| Bluebox Precision Medicine Fund | 2.23 |
| Net Receivables/Payables | -0.12 |
Sector Allocation
| Sector | Holdings (%) |
|---|
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| DSP Global Innovation Overseas Equity Omni FoF Reg IDCW | 0.0 |